Literature DB >> 10930113

Autocrine and paracrine growth inhibitors of breast cancer cells.

X L Bourhis1, R A Toillon, B Boilly, H Hondermarck.   

Abstract

Breast epithelial cells produce both mitogens and growth inhibitors which are involved in the control of mammary gland development through autocrine and paracrine pathways. While the mechanisms of action of several growth factors have been well established and related strategies proposed for breast cancer therapy, little is known concerning growth inhibitors. In this review, we present an overview of current information about major autocrine and paracrine growth inhibitors of breast epithelial cells, and we discuss their potential functions in the control of breast cancer development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930113     DOI: 10.1023/a:1006461621905

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  3 in total

1.  IL-25 causes apoptosis of IL-25R-expressing breast cancer cells without toxicity to nonmalignant cells.

Authors:  Saori Furuta; Yung-Ming Jeng; Longen Zhou; Lan Huang; Irene Kuhn; Mina J Bissell; Wen-Hwa Lee
Journal:  Sci Transl Med       Date:  2011-04-13       Impact factor: 17.956

Review 2.  Functional proteomics of breast cancer for signal pathway profiling and target discovery.

Authors:  Hubert Hondermarck; Laurent Dollé; Ikram El Yazidi-Belkoura; Anne-Sophie Vercoutter-Edouart; Eric Adriaenssens; Jérôme Lemoine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

3.  Role of insulin-like growth factor binding protein-3 in 1, 25-dihydroxyvitamin-d 3 -induced breast cancer cell apoptosis.

Authors:  C Brosseau; G Pirianov; K W Colston
Journal:  Int J Cell Biol       Date:  2013-04-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.